8-K/A

FORM 8-K AMENDMENT NO. 1

Company: TENAX THERAPEUTICS, INC.
Filed: May 7, 2010
Period of Report: May 4, 2010
Accession Number: 0001193125-10-111906

View Document ↗ View on SEC.gov ↗